29 May 2026Open access
Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantPublisher siteNature, SARS-CoV-2 and COVID-19 Research
Active, last published 2026
In hiv research and treatment
Takamasa
Ueno
Scholar“Research focused on HIV Research and Treatment and adjacent fields.”
Claim Your Profile40
H-index
8.2k
Citations
Takamasa has not officially claimed their profile. If you are Takamasa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
akamasa Ueno is a researcher working on HIV Research and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Takamasa's work has been cited 8,234 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV Research and Treatment×73SARS-CoV-2 and COVID-19 Research×49HIV/AIDS drug development and treatment×33Immune Cell Function and Interaction×27COVID-19 Clinical Research Studies×17
04 · Where I am
Affiliations
Affiliation on published researchMuhimbili University of Health and Allied Sciences, TanzaniaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works1 Dec 2025Open access
T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian PopulationPublisher siteInfection and Drug Resistance, SARS-CoV-2 and COVID-19 Research
29 Aug 2025Open access
Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trialPublisher sitePLoS ONE, HIV-related health complications and treatments
30 Jul 2025Open access
Sociodemographic and Clinical Correlates of Markers of Immune Activation, Exhaustion and Platelet Activation among HIV-Infected Patients Initiating Antiretroviral Therapy in Dar es Salaam, TanzaniaPublisher siteJapanese Journal of Infectious Diseases, HIV-related health complications and treatments
23 Dec 2024Open access
Evaluation of a surrogate virus neutralization assay for detecting neutralizing antibodies against SARS-CoV-2 in an African populationPublisher siteBiology Methods and Protocols, SARS-CoV-2 and COVID-19 Research
26 Jul 2024Open access5cites
Evaluation of cross‐neutralizing immunity following COVID‐19 primary series vaccination during the Omicron surge in TanzaniaPublisher siteJournal of Medical Virology, SARS-CoV-2 and COVID-19 Research
1 Jun 2024Open access8cites
Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236Publisher siteEBioMedicine, SARS-CoV-2 and COVID-19 Research
8 Feb 2024Open access80cites
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantPublisher siteNature Communications, SARS-CoV-2 and COVID-19 Research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Takamasa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you